BTR Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $358K | Hold |
5,040
| – | – | 0.06% | 127 |
|
|
2022
Q2 | $391K | Buy |
5,040
+65
| +1% | +$4.95K | 0.06% | 124 |
|
|
2022
Q1 | $363K | Buy |
4,975
+80
| +2% | +$5.37K | 0.04% | 136 |
|
|
2021
Q4 | $305K | Sell |
4,895
-775
| -14% | -$45.5K | 0.03% | 142 |
|
|
2021
Q3 | $335K | Sell |
5,670
-375
| -6% | -$24.7K | 0.04% | 132 |
|
|
2021
Q2 | $404K | Buy |
6,045
+1,500
| +33% | +$97.8K | 0.05% | 130 |
|
|
2021
Q1 | $287K | Sell |
4,545
-225
| -5% | -$14K | 0.04% | 144 |
|
|
2020
Q4 | $296K | Buy |
4,770
+505
| +12% | +$31.1K | 0.05% | 140 |
|
|
2020
Q3 | $257K | Sell |
4,265
-300
| -7% | -$18.1K | 0.05% | 132 |
|
|
2020
Q2 | $268K | Hold |
4,565
| – | – | 0.05% | 129 |
|
|
2020
Q1 | $254K | Sell |
4,565
-700
| -13% | -$42.8K | 0.06% | 125 |
|
|
2019
Q4 | $338K | Buy |
5,265
+1,250
| +31% | +$71.6K | 0.06% | 128 |
|
|
2019
Q3 | $204K | Buy |
+4,015
| New | +$189K | 0.04% | 160 |
|
|
2019
Q2 | – | Sell |
-4,365
| Closed | -$208K | – | 168 |
|
|
2019
Q1 | $208K | Hold |
4,365
| – | – | 0.04% | 159 |
|
|
2018
Q4 | $227K | Sell |
4,365
-100
| -2% | -$5.37K | 0.05% | 150 |
|
|
2018
Q3 | $277K | Hold |
4,465
| – | – | 0.05% | 145 |
|
|
2018
Q2 | $247K | Sell |
4,465
-35
| -0.8% | -$1.89K | 0.05% | 128 |
|
|
2018
Q1 | $285K | Sell |
4,500
-553
| -11% | -$35.6K | 0.06% | 122 |
|
|
2017
Q4 | $310K | Buy |
5,053
+350
| +7% | +$21.9K | 0.06% | 121 |
|
|
2017
Q3 | $300K | Sell |
4,703
-300
| -6% | -$17.5K | 0.06% | 119 |
|
|
2017
Q2 | $279K | Buy |
5,003
+400
| +9% | +$21.8K | 0.06% | 126 |
|
|
2017
Q1 | $250K | Buy |
4,603
+750
| +19% | +$41.1K | 0.05% | 134 |
|
|
2016
Q4 | $208K | Hold |
3,853
| – | – | 0.05% | 153 |
|
|
2016
Q3 | $208K | Buy |
3,853
+403
| +12% | +$25.9K | 0.05% | 153 |
|
|
2016
Q2 | $254K | Sell |
3,450
-75
| -2% | -$5.3K | 0.06% | 138 |
|
|
2016
Q1 | $225K | Sell |
3,525
-4,040
| -53% | -$255K | 0.05% | 143 |
|
|
2015
Q4 | $520K | Buy |
7,565
+600
| +9% | +$39.6K | 0.12% | 116 |
|
|
2015
Q3 | $412K | Sell |
6,965
-1,583
| -19% | -$100K | 0.1% | 122 |
|
|
2015
Q2 | $569K | Sell |
8,548
-100
| -1% | -$6.59K | 0.13% | 99 |
|
|
2015
Q1 | $558K | Sell |
8,648
-900
| -9% | -$56.3K | 0.14% | 99 |
|
|
2014
Q4 | $564K | Sell |
9,548
-100
| -1% | -$5.64K | 0.15% | 87 |
|
|
2014
Q3 | $494K | Buy |
9,648
+400
| +4% | +$20K | 0.14% | 93 |
|
|
2014
Q2 | $449K | Buy |
9,248
+700
| +8% | +$34.5K | 0.12% | 94 |
|
|
2014
Q1 | $444K | Hold |
8,548
| – | – | 0.13% | 95 |
|
|
2013
Q4 | $454K | Sell |
8,548
-300
| -3% | -$15.3K | 0.13% | 95 |
|
|
2013
Q3 | $409K | Hold |
8,848
| – | – | 0.13% | 98 |
|
|
2013
Q2 | $395K | Buy |
+8,848
| New | +$384K | 0.12% | 102 |
|
Other funds holding BMY
BTR Capital Management's BMY Position: Q3 2022 in Review
BTR Capital Management held its Bristol-Myers Squibb (BMY) position steady in Q3 2022 at 5,040 shares worth $358K. The position accounts for 0.06% of the portfolio, ranked #127.
BTR Capital Management first reported a position in BMY in Q2 2013 and has held it in 37 quarters since. The position peaked at $569K in Q2 2015. 2,470 funds tracked by Wall St. Rank hold BMY as of Q3 2022.
- BTR Capital Management held 5,040 shares of Bristol-Myers Squibb worth $358K as of Q3 2022.
- BTR Capital Management left its Bristol-Myers Squibb share count unchanged in Q3 2022.
- Bristol-Myers Squibb made up 0.06% of BTR Capital Management's portfolio in Q3 2022, its #127 holding.
- BTR Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 37 quarters since.
- BTR Capital Management's Bristol-Myers Squibb position peaked at $569K in Q2 2015.
- 2,470 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.
Based on BTR Capital Management's 13F filing for Q3 2022, filed 12 Oct 2022.